NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









inSoma Bio

inSoma Bio

Private
Durham, North CarolinaHealthcare & Life Scienceshttps://insomabio.com/

Last Round

Accelerator

Jun 5, 2025

Est. Valuation

$1.79M

Total Funding Raised

$10.54M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

inSoma Bio is a biotechnology company that develops bioengineered reconstructive biomaterials for plastic and reconstructive surgery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

biomaterialsreconstructive surgeryprotein engineeringregenerative medicinesoft-tissue reconstructioninjectable scaffoldbiotechmedical devicesrecombinant proteinautologous tissuethermoresponsive materialplastic surgerybio-scaffoldtissue engineeringgood manufacturing practiceGMP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

inSoma Bio Comparables

Compare inSoma Bio with similar companies based on industry and business-model similarity.

inSoma Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LifeSprout
83%
Healshape
79%
BellaSeno
79%

inSoma Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
SeedNov 1, 2023
GrantSep 1, 2023
GrantMar 31, 2023
GrantDec 15, 2022
Debt
Dec 15, 2022

inSoma Bio Investors

Notable investors and investment history

inSoma Bio investors
InvestorRounds
National Cancer InstituteGrant
MedTech InnovatorAccelerator
NIH RADxGrant
Makai VCSeed
MedBlue IncubatorSeed
Y CombinatorPre Seed, Accelerator
North Carolina Biotechnology CenterDebt, Pre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 23, 2026

    Monthly visitors increased 433% MoM.

  • Sep 1, 2023

    Received $979K from the National Science Foundation.

inSoma Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

inSoma Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about inSoma Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersDurham, North Carolina
Employee Range13
Year Founded2018
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.